Dementia News and Research

Latest Dementia News and Research

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

A new study posted to the pre-print server medRxiv* investigated the significant immune alterations concerning SARS-CoV-2 specific innate and adaptive immunity associated with a lower BNT162b2 mRNA vaccine response in older individuals.

10 Jan 2022

Improving air quality may reduce dementia risk in older women

Improving air quality appears to slow cognitive decline and reduce the risk of developing dementia in older women living in the U.S., according to a new study by researchers from the Keck School of Medicine of USC.

10 Jan 2022

Black-owned hospice seeks to bring greater ease in dying to Black families

This time, it didn’t take much persuading for Mary Murphy to embrace home hospice. When her mother was dying from Alzheimer’s disease in 2020, she had been reluctant until she saw what a help it was. So when her husband, Willie, neared the end of his life, she embraced hospice again.

10 Jan 2022

Comparison of COVID-19 and influenza-associated complications

Researchers compare the number, types, and risk for complications among COVID-19 and influenza patients using claims data.

9 Jan 2022

Physical activity may help boost synaptic functioning in older adults

When elderly people stay active, their brains have more of a class of proteins that enhances the connections between neurons to maintain healthy cognition, a UC San Francisco study has found.

7 Jan 2022

Study estimates the global prevalence of dementia in 2050

The number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 million in 2050, due primarily to population growth and population aging.

6 Jan 2022

Statistical analysis reveals less severe COVID-19 outcome due to Omicron variant

A new study demonstrated that in the US, the COVID-19 cases arising after the emergence of the SARS-CoV-2 Omicron variant showed reduced severity of infection than in the cases recorded in previous time points (during the Delta variant outbreak).

5 Jan 2022

A closer look at the relationship between COVID-19 and Alzheimer’s disease

Researchers discuss the findings of previous studies on the role of SARS-CoV-2 infection in the progression of Alzheimer's Disease.

4 Jan 2022

New Potocsnak Longevity Institute aims to extend human 'healthspan'

In the not-too-distant future, you'll be able to check into the Human Longevity Laboratory to find out how old you really are, physiologically speaking.

4 Jan 2022

As covid hits nursing homes’ finances, town residents fight to save Alzheimer’s facility

Marvin Querry, 86, was on his tractor, planting rye on his 770-acre western Missouri farm, when the call came in early November.

4 Jan 2022

Combination of rifampicin and resveratrol helps stop dementia, finds study

Dementia is thought to occur when proteins called amyloid-β, tau, and α-synuclein accumulate in the brain and form oligomers. A research group from the Department of Translational Neuroscience, Osaka City University Graduate School of Medicine, had previously shown in a study using mice that the antibiotic rifampicin removes oligomers from the brain and improves cognitive function.

29 Dec 2021

Study finds abrupt decline in the prevalence of cognitive impairment among older Americans

A new nationally representative study published online in the Journal of Alzheimer's Disease found an abrupt decline in the prevalence of cognitive impairment among American adults aged 65 and older compared to the same age group a decade earlier.

26 Dec 2021

Single-patient pilot study shows the ability of antisense oligonucleotide to suppress mutant ALS gene

Using a short, synthetic chain of chemically modified nucleotides engineered in the RNA Therapeutics Institute at UMass Chan Medical School, Robert H. Brown Jr., DPhil, MD, Jonathan Watts, PhD, and colleagues have shown the ability to suppress mutant forms of an ALS gene known as C9ORF72 in a single-patient pilot study.

24 Dec 2021

Laws shield hospitals from families who believe loved ones contracted covid as patients

After Amanda Wilson lost her son, Braden, 15, to covid-19 in early 2021, she tried to honor his memory. She put up a lending library box in his name. She plans to give the money she saved for his college education to other teens who love the arts and technology.

24 Dec 2021

Study finds abrupt decline in the prevalence of cognitive impairment among older American adults

23 Dec 2021

New study shines light on how brain cells die in prion diseases

Prion diseases, such as Creutzfeldt-Jakob Disease (CJD), are fast-moving, fatal dementia syndromes associated with the formation of aggregates of the prion protein, PrP.

22 Dec 2021

Academic education can have a positive influence on brain aging

The benefits of good education and lifelong learning extend into old age. The initial findings of a long-term study show that certain degenerative processes are reduced in the brains of academics. Their brains are better able to compensate age-related cognitive and neural limitations.

22 Dec 2021

Star-shaped cells in the brain regulate cognitive flexibility

As we live in a dynamically changing environment, it is important for our brain to not only learn new things but also to modify existing memories.

21 Dec 2021

Understanding SARS-CoV-2-induced systemic amyloidosis

A new study proposed that inflammation combined with aggregates of amyloidogenic peptides of SARS-CoV-2 S proteins might induce systemic amyloidosis.

21 Dec 2021

Study focuses on inherited Alzheimer’s up to 25 years before expected dementia onset

Washington University School of Medicine in St. Louis is launching an international clinical trial aimed at preventing Alzheimer's disease in people genetically destined to develop the illness at a young age. Unlike most other Alzheimer's prevention trials, this one will enroll people before the disease has taken hold - up to 25 years before the expected onset of dementia.

21 Dec 2021

Dementia News and Research

Latest Dementia News and Research

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

Improving air quality may reduce dementia risk in older women

Black-owned hospice seeks to bring greater ease in dying to Black families

Comparison of COVID-19 and influenza-associated complications

Physical activity may help boost synaptic functioning in older adults

Study estimates the global prevalence of dementia in 2050

Statistical analysis reveals less severe COVID-19 outcome due to Omicron variant

A closer look at the relationship between COVID-19 and Alzheimer’s disease

New Potocsnak Longevity Institute aims to extend human 'healthspan'

As covid hits nursing homes’ finances, town residents fight to save Alzheimer’s facility

Combination of rifampicin and resveratrol helps stop dementia, finds study

Study finds abrupt decline in the prevalence of cognitive impairment among older Americans

Single-patient pilot study shows the ability of antisense oligonucleotide to suppress mutant ALS gene

Laws shield hospitals from families who believe loved ones contracted covid as patients

Study finds abrupt decline in the prevalence of cognitive impairment among older American adults

New study shines light on how brain cells die in prion diseases

Academic education can have a positive influence on brain aging

Star-shaped cells in the brain regulate cognitive flexibility

Understanding SARS-CoV-2-induced systemic amyloidosis

Study focuses on inherited Alzheimer’s up to 25 years before expected dementia onset

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dementia News and Research

Latest Dementia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in